LAVIPHARM

AMENDMENT OF THE 2023 FINANCIAL CALENDAR

Paiania, 27 April 2023 - Lavipharm S.A, pursuant to articles 4.1.2 & 4.1.3.15.1 of the Athens Stock Exchange Rulebook, and as part of providing accurate and timely information to the investment community, announces the amended Financial Calendar of 2023. The amendment refers to the Analysts' Annual Briefing that will take place with physical presence on Tuesday, 16 May 2023. The Financial Calendar is updated as follows:

Thursday, 4 May 2023

Announcement of update on the 1Q.2023 Financial Results

Tuesday, 16 May 2023

Analysts' Annual Briefing will take place at Hellenic Fund and Asset Management Association (Athens Exchange, Room Hermes, at 9:30am)

Thursday, 6 July 2023

Ordinary Annual Shareholders Meeting

Thursday, 21 September 2023

Announcement of the 1H.2023 Financial Report

Wednesday, 8 November 2023

Announcement of update on 9M.2023 Financial Results

The Company will not distribute dividend for the FY 2022.

Lavipharm reserves the right to change the aforementioned dates, following relevant and timely notification to the public by amending the present, in accordance with the provisions of the ATHEX Rulebook.

###

For more information:

Investor Relations

Lavipharm

Tel.: +30 210 6691 121

Email : ir@lavipharm.com

AMENDMENT OF THE 2023 FINANCIAL CALENDAR

Attachments

Disclaimer

Lavipharm SA published this content on 27 April 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 April 2023 07:57:01 UTC.